Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Abbott reveals compounds for controlling synaptic transmission

April 3, 1997

New epilepsy option approved in the U.S.

April 2, 1997

Guilford's neuroimmunophilin ligands covered by U.S. patent

April 2, 1997

Cationized AVP fragment for learning and memory disorders from Yakult

April 2, 1997

New device for carpal tunnel syndrome

April 2, 1997

MS&D prepares antimigraine pyrrolo-pyridine derivatives

April 2, 1997

Cytogen's Quadramet approved by FDA

April 1, 1997

Syrup formulation of Zofran available in the U.K.

April 1, 1997

U.K. introduction for intranasal sumatriptan

April 1, 1997

Neuroprotective effect of hCNTF in primate model of Huntington's disease

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...